Completed NA INTERVENTIONAL NCT01058135

Effects of Hi-maize Resistant Starch on Insulin Sensitivity

A Randomized, Controlled, Double-blind Crossover Study to Assess the Effects of a Dietary Fiber Ingredient, at Two Doses, on Insulin Sensitivity

Sponsor: Ingredion Incorporated

Conditions Insulin Resistance

Interventions Control (starch) Hi-maize starch (High-dose) Hi-maize starch (Low dose)

Updated 7 times since 2017 Last updated: Apr 20, 2016 Started: Jan 31, 2010 Primary completion: Sep 30, 2010 Completion: Sep 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01058135, this NA trial focuses on Insulin Resistance and remains completed. Sponsored by Ingredion Incorporated, it has been updated 7 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Jan 2026 — Present [monthly]

Completed NA
Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 2 earlier versions

Sep 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Sep 2017 [monthly]

Completed NA

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ingredion Incorporated

Data source: Ingredion Incorporated

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Glen Ellyn, United States